Consort Medical PLC (LSE:CSRN) - Overview

Stock Report

Consort Medical PLC CSRN

Last Price
£-

Day Change
-|-%

As of -
- | GBP
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap506.90Mil
52-Wk Range-
Yield %-
ISINGB00BQJZTM21
Volume-
P/E-
P/S-
P/CF-

Share Price

Total Returns 28/09/2015

 Chg (%)  
More ...
Consort Medical PLC0.00 
FTSE 100 TR GBP-1.21
 
Financials
201420152016
More ...
Income Statement
Turnover100.01184.83276.91
Operating Profit17.418.1615.96
Net Profit13.656.2615.97
Reported EPS40.4115.2032.30
Balance Sheet
Current Assets64.03141.94110.90
Non Current Assets79.70329.83334.86
Total Assets143.73471.77445.76
Current Liabilities17.87221.93178.78
Total Liabilities25.20271.28236.61
Total Equity118.52200.49209.15
Cash Flow
Operating Cash Flow17.9818.0546.75
Net Change in Cash-11.0620.35-28.39
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
201734.5757.029.7618.061.8519.301.87
201837.7962.7310.0116.421.6419.301.87
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
07/11/2016in Lieu of DividendMr. Richard Cotton1,153.0013150.00
07/11/2016PurchaseMr. Jon Glenn1,153.0013150.00
21/10/2016in Lieu of DividendMr. Richard Cotton1,168.5813152.00
21/10/2016in Lieu of DividendMr. Jon Glenn1,168.5884982.00

Company Profile

Consort Medical PLC is engaged in designing, development and manufacturing of specialty medical drug delivery devices and services to the pharmaceutical industry.
 

Sector

Medical Devices

Market Position

417 of 1865 Companies

Index

FTSE Small Cap ,FTSE techMARK Focus ,FTSE techMARK All Share ,FTSE All Share

Outlook

(07/09/2016) "The group continues to trade in line with the board's expectations for the current financial year on a constant currency basis"

Next Event 06/12/2016

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)17.0517.2116.27
Div Yld (E)1.872.024.36
PEG (E)1.721.490.00
ROCE12.8033.3680.66
Op Mrgn8.35-26.17-14.86
EPS Grwth9.9115.6125.03
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy5
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Peter Fellner
Chief Executive OfficerMr. Jon Glenn
Group Finance DirectorMr. Richard Cotton
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.